Local Institution

Leon, Guanajato, Guanajuato 37000

0 studies enrolling now · 2 studies all time

What they study most

Malignant Melanoma, Melanoma

Studies at this site

• Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab — Completed
• Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma — Stopped early